Macular Photocoagulation Study Group.Laser photocoagulation of sub-foveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial.Arch Ophthalmol1991; 109: 1220–31.
3.
Macular Photocoagulation Study Group.Laser photocoagulation of sub-foveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial.Arch Ophthalmol1991; 109: 1232–41.
FungWE. Interferon alpha 2a for treatment of age-related macular degeneration (letter).Am J Ophthalmol1991; 112: 349–50.
10.
KirkpatrickJN, DickAD, ForresterJV. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.Br J Ophthalmol1993; 77: 766–70.
11.
EnglerCB, SanderB, KoefoedP, LarsenM, VindingT, Lund-AndersenH. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.Acta Ophthalmologica1993; 71: 27–31.
12.
LoughnanMS, HeriotWJ, O'DayJ. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.Aust N Z J Ophthalmol1992; 20: 173–5.
13.
LewisML, DavisJ, ChuangE. Interferon alfa-2a in the treatment of exudative age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol1993; 231: 615–8.
14.
PolinerLS, TornambePE, MichelsonPE, HeitzmannJG. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.Ophthalmology1993; 100: 1417–24.
15.
ThomasMA, IbanezHE. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.Am J Ophthalmol1993; 115: 563–8.
16.
ChanCK, KempinS J, NobleSK, PalmerGA. The treatment of choroidal neovascular membranes by alpha interferon.Ophthalmology1994; 101: 289–300.
17.
GilliesMC, SarksJP, BeaumontPE, HunyorAB, McKayD, KearnsM. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alfa-2a and alfa-2b.Br J Ophthalmol1993; 77: 759–65.
